4Vucic S, Chong PST, Cros D. Atypical presentations of primary amyloid neuropathy. Muscle Nerve, 2003, 28:696-702.
5Li K, Kyle RA, Dyck PJ. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy. Am J Pathol, 1992, 141:217-226.
6Haan J, Peters WG. Amyloid and peripheral nervous system disease. Am Heart J, 2002, 144:122-129.
7Low PA, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve, 2003, 27:646-661.
8Mendell JR, Kissel JT, Cornblath DR. Diagnosis and management of peripheral nerve disorders. Oxford University Press, 2001, 281-282.
9Abarbanel JM, Frisher S, Osimani A. Primary amyloidosis with peripheral neuropathy and signs of motor neuron disease. Neurology, 1986, 36:1125- 1127.
10Said G. Familial amyloid polyneuropathy:mechanisms leading to nerve degeneration. Amloid, 2003, 10 Suppl 1:7-12.
二级参考文献7
1Utz JP, Swensen SJ, Gertz MA . Pulmonary amyloidosis. The Mayo clinic experience from 1980 to 1993. Ann Intern Med ,1996,124:407-413.
2Roger SZ, Gamold MP ,Marta VO, et al. Head aug neek manifestations of amyloidosis. Otolaryngology, 2001,120:553-557.
3Kyle RA , Gerte MA. Primary systemic amyloidosis : clinical aug laboratory feature in 474 cases. Semin Hematol ,1995,32:45.
4Desikan KR, Dhodapkar MV, Hough A, et al. Incidence and impact of light chain associated (AL) amyloidoais on the prognceh of patients with multiple myeloma treated with autologoustransplantation. Leuk Lymphoma,1997,27:315-319.
5Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis, specificity, positive predictive and value ,and diagnosistic pitfalls. Diagn Cytopathol, 2001,24:181-185.
6Sezer JO,Eucker J, Schmid P,et al. New therapeutic approaches in primary systemic AL amyloidosis. Ann Hematol ,2000,79 : 1-6.
3Sezer JO, Euker J, Schmid R, et al. New therapeutic approaches in primary systemic AL amyloidosis. Ann Hematol, 2000, 79: 1-6.
4Comenzo RL, Vosburgh E, Simms RW, et al. Dose intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one year follow up in five patients. Blood, 1996, 88: 2801-2806.
5Walley VM, Kisilevsky R, Young ID. Amyloid and cardiovascular system: a review of pathogenesis and pathology with clinic correlations. Cardiovascular pathology, 1995, 4:79-102.
